• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Data Knights Acquisition Corp.

    4/11/23 12:00:45 PM ET
    $DKDCA
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $DKDCA alert in real time by email
    SC 13G 1 p23-1288sc13g.htm DATA KNIGHTS ACQUISITION CORP.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
     
    SCHEDULE 13G
     
     
     
    Under the Securities Exchange Act of 1934
     
    (Amendment No.  )*
     

    Data Knights Acquisition Corp.

    (Name of Issuer)
     

    Class A Common Stock, par value $0.0001 per share

     (Title of Class of Securities)
     

    237699103

    (CUSIP Number)
     

    December 31, 2022

    (Date of Event Which Requires Filing of this Statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
     
    ¨ Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    x Rule 13d-1(d)
     
    (Page 1 of 8 Pages)

     

    ______________________________

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 23769910313GPage 2 of 8 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Owl Creek Asset Management, L.P.

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    - 0 -

    6

    SHARED VOTING POWER

    475,000

    7

    SOLE DISPOSITIVE POWER

    - 0 -

    8

    SHARED DISPOSITIVE POWER

    475,000

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    475,000

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    14.0%

    12

    TYPE OF REPORTING PERSON

    PN

             

     

     

    CUSIP No. 23769910313GPage 3 of 8 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Jeffrey A. Altman

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) x

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH:
    5

    SOLE VOTING POWER

    - 0 -

    6

    SHARED VOTING POWER

    475,000

    7

    SOLE DISPOSITIVE POWER

    - 0 -

    8

    SHARED DISPOSITIVE POWER

    475,000

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    475,000

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    14.0%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

     

    CUSIP No. 23769910313GPage 4 of 8 Pages

     

     

    Item 1(a). NAME OF ISSUER.
       
      The name of the issuer is Data Knights Acquisition Corp. (the "Issuer").

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Issuer's principal executive offices are located at Unit G6, Frome Business Park, Manor Road, Frome, United Kingdom, BA114FN.
    Item 2(a). NAME OF PERSON FILING:

     

      (i) Owl Creek Asset Management, L.P., a Delaware limited partnership and the investment manager of Owl Creek Credit Opportunities Master Fund, Ltd. (the "Owl Creek Fund"), with respect to the shares of Class A Common Stock owned by the Owl Creek Fund; and
       
      (ii) Jeffrey A. Altman ("Mr. Altman"), as managing member of the general partner of Owl Creek Asset Management, L.P., with respect to the shares of Class A Common Stock owned by the Owl Creek Fund.
       
      The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
       
      The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Class A Common Stock reported herein.

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

     

      The address of the principal business office of each of the Reporting Persons is 640 Fifth Avenue, 20th Floor, New York, NY 10019.

     

    Item 2(c). CITIZENSHIP:

     

      Owl Creek Asset Management, L.P. is a limited partnership organized under the laws of the State of Delaware. Mr. Altman is a United States citizen.

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Class A common stock, $0.0001 par value (the "Class A Common Stock").

     

    Item 2(e). CUSIP NUMBER:
       
      237699103

     

     

    CUSIP No. 23769910313GPage 5 of 8 Pages

     

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) ¨ Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨

    Employee benefit plan or endowment fund in accordance with

    Rule 13d-1(b)(1)(ii)(F);

     

      (g) ¨

    Parent holding company or control person in accordance with

    Rule 13d-1(b)(1)(ii)(G);

      (h) ¨

    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i) ¨

    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

      (j) ¨ Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

     

    If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

    specify the type of institution:                                                                                         

     

    Item 4. OWNERSHIP.

     

        The percentages set forth herein are calculated based upon 3,316,719 shares of  Class A Common Stock outstanding which was calculated based upon (i) 12,085,175 shares of Class A Common Stock outstanding as of November 18, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2022, filed with the Securities and Exchange Commission on November 18, 2022 and (ii) the redemption of 8,768,456 shares of Class A Common Stock by the Issuer’s shareholders, as reported in the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 15, 2022.
         
        The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person.

     

     

    CUSIP No. 23769910313GPage 6 of 8 Pages

     

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      Not applicable.

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      See Item 2.  The Owl Creek Fund has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Class A Common Stock reported herein.

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.

     

      Not applicable.

     

    CUSIP No. 23769910313GPage 7 of 8 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
       
       
    DATED:  April 11, 2023  
       
       
      /s/ Jeffrey A. Altman
      Jeffrey A. Altman, individually and as managing member of the general partner of Owl Creek Asset Management, L.P.

     

     

     

    CUSIP No. 23769910313GPage 8 of 8 Pages

     

    EXHIBIT 1

    JOINT ACQUISITION STATEMENT
    PURSUANT TO RULE 13d-1(k)

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

    DATED:  April 11, 2023  
       
       
      /s/ Jeffrey A. Altman
      Jeffrey A. Altman, individually and as managing member of the general partner of Owl Creek Asset Management, L.P.

     

     

    Get the next $DKDCA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DKDCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DKDCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Casey Paul claimed ownership of 599,172 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 4:18:48 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • New insider Kosasa Thomas claimed ownership of 4,952,409 shares (SEC Form 3)

      3 - OneMedNet Corp (0001849380) (Issuer)

      11/15/23 2:08:21 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: Owl Creek Asset Management, L.P. disposed of $5,175,450 worth of shares (465,000 units at $11.13)

      4 - Data Knights Acquisition Corp. (0001849380) (Issuer)

      8/21/23 6:18:49 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/14/24 6:03:43 AM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G/A filed by Data Knights Acquisition Corp. (Amendment)

      SC 13G/A - OneMedNet Corp (0001849380) (Subject)

      2/5/24 1:55:23 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed by Data Knights Acquisition Corp.

      SC 13G - Data Knights Acquisition Corp. (0001849380) (Subject)

      4/11/23 12:00:45 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $DKDCA
    Leadership Updates

    Live Leadership Updates

    See more
    • OneMedNet Network Expands with New Partnership with Large Academic Research Medical Center to Benefit its Life Science Company Clients

      ~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD™. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-mar

      11/9/23 4:15:00 PM ET
      $DKDCA
      $ONMD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • OneMedNet Completes Business Combination with Data Knights Acquisition Corp. to Become a Publicly Traded Company

      OneMedNet Common Stock to Trade on Nasdaq Under Ticker "ONMD" Tomorrow, Wednesday, November 8, 2023OneMedNet to Fully Embark on its Growth Strategy as it Spearheads the Imaging RWD Solution in the $400 Billion Clinical MarketMINNEAPOLIS, MN / ACCESSWIRE / November 7, 2023 / OneMedNet Corporation (NASDAQ:DKDCA)(NASDAQ:DKDCW) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real World Data ("RWD"), through its proven OneMedNet iRWD™ solution, today announced that it has completed its previously announced business combination with Data Knights Acquisition Corp. ("Data Knights"). The business combination was approved at a special meeting of Data Knights' stockholde

      11/7/23 2:00:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

      MINNEAPOLIS, MN and LONDON, UK / ACCESSWIRE / October 12, 2023 / Data Knights Acquisition Corp. ("Data Knights" or the "Company") (NASDAQ:DKDCU, DKDCA, DKDCW))), a special purpose acquisition company, today announced that on October 10, 2023 it caused to be deposited $75,000 into the Company's trust account, allowing the Company to extend the period of time it has to consummate its initial business combination by one month from October 11, 2023 to November 11, 2023 (the "Extension"). The Extension is the third of nine (9) one-month extensions permitted under the Company's governing documents. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains statements

      10/12/23 4:45:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • OneMedNet Appoints Healthcare IT Executive, Aaron Green, as President

      ~ Signaling a New Chapter of Growth for the Innovative Solution of Real World Data~MINNEAPOLIS, MN / ACCESSWIRE / May 23, 2023 / OneMedNet Corporation ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Imaging Real Word Data, through its proven OneMedNet iRWD™ solution, today announced the expansion of its executive team with the appointment of healthcare technology veteran, Aaron Green, as President. In this new role, Green will be responsible for all the major growth functions and lead engagement with existing clients, new clients, sales operations, marketing, communications, and product innovation, reporting directly to the CEO.Green is a healthcare technology busines

      5/23/23 4:05:00 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $DKDCA
    SEC Filings

    See more
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - OneMedNet Corp (0001849380) (Filer)

      2/9/24 4:15:31 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form S-1 filed by Data Knights Acquisition Corp.

      S-1 - OneMedNet Corp (0001849380) (Filer)

      12/18/23 8:29:14 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Data Knights Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - OneMedNet Corp (0001849380) (Filer)

      11/22/23 5:30:12 PM ET
      $DKDCA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care